Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. It may present with vaginal bleeding but symptoms may be absent until the cancer is in advanced stages.
Treatment consists of surgery (including local excision) in the early stages and chemotherapy and radiology in advanced stages of the disease.
Pap smear screening can identify potentially pre-cancerous changes. Treatment of high grade changes can prevent the development of cancer. In developed countries, the wide spread use of cervical screening is programs has reduced the incidence of invasive cervical cancer by 50% or more. Human Papilloma virus (HPV) infection is a necessary factor in the development of nearly 70% of cases of cervical cancer.
HPV vaccine effective against the two strains of HPV that cause the most cervical cancer has been licensed in the US, Canada, Australia and the EU. These two HPV strains together are currently responsible for 70% of all cervical cancers. Since the vaccine only covers some high risk types, women should seek regular Pap smear screening even after vaccination. For further infomation, send an e-mail to [email protected]